197 related articles for article (PubMed ID: 16024664)
1. Reactive oxygen species elicit apoptosis by concurrently disrupting topoisomerase II and DNA-dependent protein kinase.
Lu HR; Zhu H; Huang M; Chen Y; Cai YJ; Miao ZH; Zhang JS; Ding J
Mol Pharmacol; 2005 Oct; 68(4):983-94. PubMed ID: 16024664
[TBL] [Abstract][Full Text] [Related]
2. Salvicine inactivates beta 1 integrin and inhibits adhesion of MDA-MB-435 cells to fibronectin via reactive oxygen species signaling.
Zhou J; Chen Y; Lang JY; Lu JJ; Ding J
Mol Cancer Res; 2008 Feb; 6(2):194-204. PubMed ID: 18314480
[TBL] [Abstract][Full Text] [Related]
3. Induction of apoptosis by plumbagin through reactive oxygen species-mediated inhibition of topoisomerase II.
Kawiak A; Piosik J; Stasilojc G; Gwizdek-Wisniewska A; Marczak L; Stobiecki M; Bigda J; Lojkowska E
Toxicol Appl Pharmacol; 2007 Sep; 223(3):267-76. PubMed ID: 17618663
[TBL] [Abstract][Full Text] [Related]
4. DNA damage, c-myc suppression and apoptosis induced by the novel topoisomerase II inhibitor, salvicine, in human breast cancer MCF-7 cells.
Lu HR; Meng LH; Huang M; Zhu H; Miao ZH; Ding J
Cancer Chemother Pharmacol; 2005 Mar; 55(3):286-94. PubMed ID: 15592835
[TBL] [Abstract][Full Text] [Related]
5. Salvicine triggers DNA double-strand breaks and apoptosis by GSH-depletion-driven H2O2 generation and topoisomerase II inhibition.
Cai YJ; Lu JJ; Zhu H; Xie H; Huang M; Lin LP; Zhang XW; Ding J
Free Radic Biol Med; 2008 Sep; 45(5):627-35. PubMed ID: 18582559
[TBL] [Abstract][Full Text] [Related]
6. Salvicine, a novel topoisomerase II inhibitor, exerts its potent anticancer activity by ROS generation.
Meng LH; Ding J
Acta Pharmacol Sin; 2007 Sep; 28(9):1460-5. PubMed ID: 17723179
[TBL] [Abstract][Full Text] [Related]
7. GS-2, a pyrazolo[1,5-a]indole derivative with inhibitory activity of topoisomerases, exerts its potent cytotoxic activity by ROS generation.
Ji YY; Zhu YM; Wang JW
Environ Toxicol Pharmacol; 2013 Nov; 36(3):1186-96. PubMed ID: 24184570
[TBL] [Abstract][Full Text] [Related]
8. Salvicine functions as novel topoisomerase II poison by binding to ATP pocket.
Hu CX; Zuo ZL; Xiong B; Ma JG; Geng MY; Lin LP; Jiang HL; Ding J
Mol Pharmacol; 2006 Nov; 70(5):1593-601. PubMed ID: 16914642
[TBL] [Abstract][Full Text] [Related]
9. Transcription factor c-Jun activation represses mdr-1 gene expression.
Miao ZH; Ding J
Cancer Res; 2003 Aug; 63(15):4527-32. PubMed ID: 12907627
[TBL] [Abstract][Full Text] [Related]
10. Farnesyltransferase inhibitors induce DNA damage via reactive oxygen species in human cancer cells.
Pan J; She M; Xu ZX; Sun L; Yeung SC
Cancer Res; 2005 May; 65(9):3671-81. PubMed ID: 15867362
[TBL] [Abstract][Full Text] [Related]
11. Reactive oxygen species contribute to cell killing and P-glycoprotein downregulation by salvicine in multidrug resistant K562/A02 cells.
Cai Y; Lu J; Miao Z; Lin L; Ding J
Cancer Biol Ther; 2007 Nov; 6(11):1794-9. PubMed ID: 18032928
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effects of dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, in human liver cancer cells are mediated through a reactive oxygen species-dependent mechanism.
Lampiasi N; Azzolina A; D'Alessandro N; Umezawa K; McCubrey JA; Montalto G; Cervello M
Mol Pharmacol; 2009 Aug; 76(2):290-300. PubMed ID: 19461054
[TBL] [Abstract][Full Text] [Related]
13. Salvicine, a novel DNA topoisomerase II inhibitor, exerting its effects by trapping enzyme-DNA cleavage complexes.
Meng LH; Zhang JS; Ding J
Biochem Pharmacol; 2001 Sep; 62(6):733-41. PubMed ID: 11551518
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity, apoptosis induction and downregulation of MDR-1 expression by the anti-topoisomerase II agent, salvicine, in multidrug-resistant tumor cells.
Miao ZH; Tang T; Zhang YX; Zhang JS; Ding J
Int J Cancer; 2003 Aug; 106(1):108-15. PubMed ID: 12794765
[TBL] [Abstract][Full Text] [Related]
15. Cadmium activates the mitogen-activated protein kinase (MAPK) pathway via induction of reactive oxygen species and inhibition of protein phosphatases 2A and 5.
Chen L; Liu L; Huang S
Free Radic Biol Med; 2008 Oct; 45(7):1035-44. PubMed ID: 18703135
[TBL] [Abstract][Full Text] [Related]
16. DNA topoisomerase II as the primary cellular target for salvicine in Saccharomyces cerevisiae.
Meng LH; He XX; Zhang JS; Ding J
Acta Pharmacol Sin; 2001 Aug; 22(8):741-6. PubMed ID: 11749849
[TBL] [Abstract][Full Text] [Related]
17. Sodium salicylate is a novel catalytic inhibitor of human DNA topoisomerase II alpha.
Bau JT; Kurz EU
Biochem Pharmacol; 2011 Feb; 81(3):345-54. PubMed ID: 20959117
[TBL] [Abstract][Full Text] [Related]
18. Induction of bulk and c-myc P2 promoter-specific DNA damage by an anti-topoisomerase II agent salvicine is an early event leading to apoptosis in HL-60 cells.
Meng L; Ding J
FEBS Lett; 2001 Jul; 501(1):59-64. PubMed ID: 11457456
[TBL] [Abstract][Full Text] [Related]
19. A cysteine-reactive alkyl hydroquinone modifies topoisomerase IIα, enhances DNA breakage, and induces apoptosis in cancer cells.
Lin TY; Huang CP; Au LC; Chang YW; Hu CY; Lin SB
Chem Res Toxicol; 2012 Nov; 25(11):2340-51. PubMed ID: 23088786
[TBL] [Abstract][Full Text] [Related]
20. Sodium salicylate acts through direct inhibition of phosphoinositide 3-kinase-like kinases to modulate topoisomerase-mediated DNA damage responses.
Fan JR; Huang TH; Wen CY; Shen TL; Li TK
Eur J Pharmacol; 2010 Jul; 638(1-3):13-20. PubMed ID: 20406630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
